Health & Environmental Research Online (HERO)


Print Feedback Export to File
3860066 
Journal Article 
Comparative hepatotoxicity of 6:2 fluorotelomer carboxylic acid and 6:2 fluorotelomer sulfonic acid, two fluorinated alternatives to long-chain perfluoroalkyl acids, on adult male mice 
Sheng, N; Zhou, X; Zheng, F; Pan, Y; Guo, X; Guo, Y; Sun, Y; Dai, J 
2017 
Yes 
Archives of Toxicology
ISSN: 0340-5761
EISSN: 1432-0738 
91 
2909-2919 
English 
is supplemented by 3986417 - Supplementary material
Due to their structural similarities, 6:2 fluorotelomer sulfonic acid (6:2 FTSA) and 6:2 fluorotelomer carboxylic acid (6:2 FTCA) are often used as alternatives to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA), respectively. With limited health risk data and 6:2 FTSA detection in water and sludge, the toxicity of these chemicals is of growing concern. Here, adult male mice were exposed with 5 mg/kg/day of 6:2 FTCA or 6:2 FTSA for 28 days to investigate their hepatotoxicological effects. In contrast to 6:2 FTCA, 6:2 FTSA was detected at high and very high levels in serum and liver, respectively, demonstrating bioaccumulation potential and slow elimination. Furthermore, 6:2 FTSA induced liver weight increase, inflammation, and necrosis, whereas 6:2 FTCA caused no obvious liver injury, with fewer significantly altered genes detected compared with that of 6:2 FTSA (39 vs. 412). Although PFOA and PFOS commonly activate peroxisome proliferator-activated receptor α (PPARα), 6:2 FTSA induced an increase in PPARγ and related proteins, but not in lipid metabolism-related genes such as PPARα. Our results showed that 6:2 FTCA and 6:2 FTSA exhibited weak and moderate hepatotoxicity, respectively, compared with that reported for legacies PFOA and PFOS. 
6: 2 FTCA; 6: 2 FTSA; Comparative hepatotoxicity; PFAAs alternatives 
• Additional PFAS (formerly XAgency)
     Literature Search November 2019
          PubMed
          Web of Science
          ToxNet
          Other Sources
               TEDX
     Screened Studies
          Included
               Include (TIAB)
               Include (Full Text)
          Supplemental
     2-Perfluorooctyl ethanoic acid
• Expanded PFAS SEM (formerly PFAS 430)
     Litsearch: September 2019
          PubMed
          Web of Science
          Other Sources
               PFAS TOX Database
     Screened Studies
          Excluded
               Exclude (TIAB)
     Not prioritized for screening
     6:2 Fluorotelomer sulfonic acid
     Perfluorooctane
     Potassium perfluorooctanoate
     Sodium perfluorooctanoate
     2-(Perfluorohexyl)ethanoic acid
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFOA (335-67-1) and PFOS (1763-23-1)
          Literature Search – Adverse outcome pathway (2015-present)
               Pubmed
               WOS
     FtS 6:2 (27619-97-2)
          Literature Search
               Pubmed
• PFAS 150
     Literature Search Update December 2020
          PubMed
          WOS
     Literature Search August 2019
          PubMed
          Web of Science
          Other sources
               PFAS TOX Database
     Not prioritized for screening
     6:2 Fluorotelomer sulfonic acid
     Ammonium perfluorooctanoate
     Perfluorooctane
     Perfluorooctanesulfonic acid
     Perfluorooctanoic acid
• PFNA
     Litsearch Update 2017-2018
          Pubmed
          Toxline
     Literature Search
          Pubmed
          Toxline
     PFNA May 2019 Update
          Toxnet
     Title and Abstract Screening
          Full Text Screening
               Excluded
                    Not PFNA
• PFOA (335-67-1) and PFOS (1763-23-1)
     Literature Search – Adverse outcome pathway (2015-present)
          Pubmed
          WOS
     Screening Results
          Excluded/Not on Topic
     Literature Search Update (2013-2019)
          PubMed
          WOS
• Yale PFAS Liver study